Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker

American Journal of Pathology

Volumn 151, Issue 4, 1997, Pages 1153-1161

  Larramendy, Marcelo L ^a,b   Tarkkanen, Maija ^a   Blomqvist, Carl ^a   Virolainen, Martti ^a   Wiklund, Tom ^a   Asko Seljavaara, Sirpa ^a   Elomaa, Inkeri ^a   Knuutila, Sakari ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b FACULTAD DE CIENCIAS NATURALES Y MUSEO   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CHROMOSOME 13Q; CHROMOSOME 1P; CHROMOSOME 5P; CHROMOSOME 7Q; CHROMOSOME 9Q; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; PROGNOSIS; SOFT TISSUE NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030866135     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Enzinger FM, Weiss SW: (1995) Malignant fibrohistiocytic tumors. Soft Tissue Tumors. St. Louis, CV Mosby, 1995, pp 351-380
2. Markhede G, Angervall L, Stener B: A multivariate analysis of the prognosis after surgical treatment of malignant soft-tissue tumors. Cancer 1982, 49:1721-1733
3. Hashimoto H, Daimaru Y, Takeshita S, Tsuneyoshi M, Enjoii M: Prognostic significance of histologic parameters of soft tissue sarcomas. Cancer 1992, 70:2816-2822
4. Weiss SW: Histological Typing of Soft Tissue Tumours. Berlin, Springer-Verlag, 1994
5. Le Doussal V, Coindre J-M, Leroux A, Hacene K, Terrier P, Binh Bui N, Bonichon F, Collin F, Mandard A-M, Contesso G: Prognostic factors for patients with localized primary malignant fibrous histiocytoma. Cancer 1996, 77:1823-1830
6. Rööser BO, Willén H, Gustafson P, Alvegård TA, Rydholm A: Malignant fibrous histiocytoma of soft tissue: a population-based epidemiologic and prognostic study of 137 patients. Cancer 1991, 67:499-505
7. Pezzi ME, Rawling MS, Esgro JJ, Polock RE, Romsdahl MM: Prognostic factors in 227 patients with malignant fibrous histiocytoma. Cancer 1992, 69:2098-2103
8. Zagars GK, Mullen JR, Pollack A: Malignant fibrous histiocytoma: outcome and prognostic factors following conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys 1996, 34:983-994
9. Gustafson P: Soft tissue sarcoma: epidemiology and prognosis in 508 patients. Acta Orthop Scand 1994, 65:1-31
10. Mandahl N, Heim S, Arheden K, Rydholm A, Willen H, Mitelman F: Rings, dicentrics and telomeric association in histiocytomas. Cancer Genet Cytogenet 1988, 30:23-33
11. Mandahl N, Willen H, Rydholm A, Eneroth M, Nilbert M, Kreicbergs A, Mitelman F: Characteristic karyotypic anomalies identify subtypes of malignant fibrous histiocytoma. Genes Chromosomes & Cancer 1989, 1:9-14
12. Mandahl N: Cytogenetics and molecular genetics of bone and soft tissue tumors. Adv Cancer Res 1996, 69:63-99
13. Szymanska J, Tarkkanen M, Wiklund T, Virolainen M, Blomqvist C, Asko-Seljavaara S, Tukiainen E, Elomaa I, Knuutila S: A cytogenetic study of malignant fibrous histiocytoma. Cancer Genet Cytogenet 1995, 85:91-96
14. Rydholm A, Mandahl N, Heim S, Kreicbergs, Willen H, Mitelman F: Malignant fibrous histiocytomas with a 19p+ marker have increased relapse rate. Genes Chromosomes & Cancer 1990, 2:296-299
15. Choong PFM, Mandahl N, Mertens F, Willén H, Alvegåard T, Kreicbergs A, Mitelman F, Rydholm A: 19p+ marker chromosome correlates with relapse in malignant fibrous histiocytoma. Genes Chromosomes & Cancer 1996, 16:88-93
16. Nilbert M, Mandahl N, Åman P, Rydholm A, Mitelman F: No rearrangements of the CHOP gene in malignant fibrous histiocytoma. Cancer Genet Cytogenet 1995, 72:155-156
17. Nilbert M, Rydholm A, Mitelman F, Meltzer PS, Mandahl N: Characterization of the 12q13-15 amplicon in soft tissue tumors. Cancer Genet Cytogenet 1995, 83:32-36
18. Nilbert M, Rydholm A, Willén H, Mitelman F, Mandahl N: MDM2 gene amplification correlates with ring chromosomes in soft tissue tumors. Genes Chromosomes & Cancer 1994, 9:261-265
19. Smith SH, Weiss SW, Jankowski SA, Coccia MA, Meltzer PS: SAS amplification in soft tissue sarcomas. Cancer Res 1992, 52:3746-3749
20. Meltzer PS, Jankowski SA, Dal Cin P, Sandberg AA, Paz IB, Coccia MA: Identification and cloning of a novel amplified DNA sequence in human malignant fibrous histiocytoma derived from a region of chromosome 12 frequently rearranged in soft tissue tumors. Cell Growth Differ 1991, 2:495-501
21. Jankowski SA, Mitchell DS, Smith SH, Trent JM, Meltzer PS: SAS, a gene amplified in human sarcomas, encodes a new member of the transmembrane 4 superfamily of proteins. Oncogene 1994, 9:1205-1211
22. Wadayama B, Toguchida J, Yamaguchi T, Sasaki MS, Kotoura Y, Yamamuro T: p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. Br J Cancer 1993, 68:1134-1139
23. Wunder JS, Czitrom AA, Kandel R, Andrulis IL: Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas. J Natl Cancer Inst 1991, 83:194-200
24. Wiklund T, Huuhtanen R, Blomqvist C, Tukiainen E, Virolainen M, Virkkunen P, Asko-Seljavaara S, Björkenheim JM, Elomaa I: Importance of a multidisciplinary group in the treatment of soft tissue sarcomas. Eur J Cancer 1996, 32:269-273
25. Larramendy ML, Tarkkanen M, Valle J, Kivioja AH, Ervasti H, Karaharju E, Salmivalli T, Elomaa I, Knuutila S: Gains, losses, and amplifications of DNA sequences evaluated by comparative genomic hybridization in chondrosarcomas. Am J Pathol 1997, 150:685-691
26. Schrock E, Thiel G, Lozanova T, du Manoir S, Meffert M-C, Jauch A, Speicher MR, Nürnberg P, Vogel S, Jänisch W, Donis-Keller H, Ried T, Witkowski R, Cremer T: Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am J Pathol 1994, 144: 1203-1218
27. Kallioniemi A, Kallioniemi O-P, Citro G, Sauter G, DeVries S, Kerschmann R, Caroll P, Waldman F: Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes & Cancer 1995, 12: 213-219
28. Tarkkanen M, Karhu R, Kallioniemi A, Elomaa I, Kivioja AH, Nevalainen J, Bo̊hling T, Karaharju E, Hyytinen E, Knuutila S, Kallioniemi O-P: Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization. Cancer Res 1995, 55:1334-1338
29. Szymanska J, Tarkkanen M, Wiklund T, Virolainen M, Blomqvist C, Asko-Seljavaara S, Tukiainen E, Elomaa I, Knuutila S: Gains and losses of DNA sequences in liposarcomas evaluated by comparative genomic hybridization. Genes Chromosomes & Cancer 1996, 15: 89-94
30. McAlpine PJ, Shows TB, Boucheix C, Huebner M, Anderson WA: The 1991 catalog of mapped genes and report of the nomenclature committee. Human Gene Mapping 11. Cytogenet Cell Genet 1991, 58:5-102
31. El-Rifai W, Sarlomo-Rikala M, Miettinen M, Knuutila S, Andersson LC: DNA copy number losses in chromosome 14: an early change in gastrointestinal stromal tumors. Cancer Res. 1996, 56:3230-3233
32. Ried T, Knutzen R, Steinbeck R, Biegen H, Schröck E, Heselmeyer K, du Manoir S, Auer G: Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes & Cancer 1996, 15:234-245
33. Ried T, Petersen I, Holtgreve-Grez H, Speicher MR, Schröck E, du Manoir S, Cremer T: Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization Cancer Res 1994, 54:1801-1806
34. Speicher MR, Howe C, Crotty P, du Manoir S, Costa J, Ward DC: Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res 1995, 55:1010-1013
35. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS3, Johnson BE, Skolnick MH: A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994, 264:436-440
36. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994, 368:753-756
37. Cheng JQ, Jhanwar SC, Kelin WM, Bell DW, Lee W-C, Altomare DA, Nobori T, Olopade OIO, Buckler AJ, Testa JR: p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res 1994, 54:5547-5551
38. Heim S, Mitelman F: Cancer Cytogenetics, ed 2. New York, Wiley-Liss, 1995
39. Schlegel J, Stumm G, Scherthan H, Bocker T, Zirngibl H, Ruschoff J, Hofstädter F: Comparative genomic hybridization of colon carcinomas with replication error. Cancer Res 1995, 55:6002-6005
40. Kim DH, Mohapatra G, Bollen A, Waldman FM, Feuerstein BG: Chromosomal abnormalities in glioblastoma multiforme tumors and glioma cell lines detected by comparative genomic hybridization. Int J Cancer 1995, 60:812-819
41. Joos S, Bergerheim USR, Pan Y, Matsuyama H, Bentz M, du Manoir S, Lichter P: Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization. Genes Chromosomes & Cancer 1995, 14:267-276
42. Gordon KB, Thompson CT, Char DH, O'Brien JM, Kroll S, Ghazvini S, Gray JW: Comparative genomic hybridization in the detection of DNA copy number abnormalities in uveal melanoma. Cancer Res 1994, 54:4764-4768
43. Weber-Hall S, Anderson J, McManus A, Abe S, Nojima T, Pinkerton R, Pritchard-Jones K, Shipley J: Gains, losses, and amplifications of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization. Cancer Res 1996, 56:3230-3224
44. Iwabuchi H, Sakamoto M, Sakunaga H, Ma Y-Y, Carcangiu ML, Pinkel D, Yang-Feng TL, Gray JW: Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res 1995, 55:6172-6180
45. Wolf M, Aaltonen L, Szymanska J, Tarkkanen M, Blomqvist C, Berner J-M, Myklebost O, Knuutila S: Complexity of 12q13-22 amplicon in liposarcoma: microsatellite repeat analysis. Genes Chromosomes & Cancer 1997, 18:66-70
46. Szymanska J, Mandahl N, Mertens F, Tarkkanen M, Karaharju E, Knuutila S: Ring chromosomes in parosteal osteosarcoma contain sequences from 12q13-15: a combined cytogenetic and comparative genomic hybridization study. Genes Chromosomes & Cancer 1996, 16:31-34
47. Monni O, Joensuu H, Franssila K, Klefstrom J, Alitalo K, Knuutila S: BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma. Blood 1997, 90:1168-1174
48. Friend SH, Horowitz JM, Gerber MR, Wang X-F, Bogenmann E, Li FP, Weinberg RA: Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein. Proc Natl Acad Sci USA 1987, 84:9059-9063
49. Forus A, Weghuis DO, Smeets D, Fodstad Ø, Myklebost O, van Kessel AG: Comparative genomic hybridization analysis of human sarcomas. I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas. Genes Chromosomes & Cancer 1995, 14:8-14
50. Isola J, Kallioniemi O, Chu L, Fuqua S, Hilsenbeck S, Osborne K, Waldman F: Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol 1995, 147:905-911
51. Moch H, Presti JC, Sauter G, Buchholz N, Jordan P, Mihatsch MJ, Waldman FM: Genetic aberrationes detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Cancer Res 1996, 56:27-30
52. Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jockei K-H, Becher R: Prognostic implications of monosomy 3 in uveal melanoma. Lancet 1996, 347:1222-1225